[EN] AMINOPYRIMIDINE HETEROCYCLIC COMPOUND WITH ADENOSINE RECEPTOR ANTAGONISTIC ACTIVITY<br/>[FR] COMPOSÉ AMINOPYRIMIDINE HÉTÉROCYCLIQUE PRÉSENTANT UNE ACTIVITÉ ANTAGONISTE DU RÉCEPTEUR DE L'ADÉNOSINE
申请人:SUZHOU YUNXUAN YIYAO KEJI YOUXIAN GONGSI
公开号:WO2017088755A1
公开(公告)日:2017-06-01
Disclosed hereinis an aminopyrimidine heterocyclic compound with adenosine receptor antagonistic activity, comprising a compound of the general formula (I), or a pharmaceutically acceptable salt thereof. The aminopyrimidine heterocyclic compound with adenosine receptor antagonistic activitydisclosed herein can be used as an effective adenosine receptor antagonist, and can be used for the treatment or prevention of disorders caused by abnormal level of adenosine.
Quinazolines of the formula (I) in which R, R
1
, R
2
, R
3
, R
4
and Y have the meaning indicated in Patent claim 1, and their salts or solvates as glycoprotein IbIX antagonists.